CardiLect: A combined cross-species lectin histochemistry protocol for the automated analysis of cardiac remodelling

Tamás G Gergely1,2,3,4, Tamás Kovács1,2,3,4, Andrea Kovács1,2,3,4

  • 1Department of Pharmacology and Pharmacotherapy, Semmelweis University, Budapest, Hungary.

ESC Heart Failure
|November 13, 2024
PubMed

Insights

This study introduces a cost-effective, cross-species lectin histochemistry protocol for assessing cardiac remodelling. The new method accurately measures cardiomyocyte size and microvascular density, correlating well with heart failure indicators.

Area of Science:

  • Cardiovascular Research
  • Histology and Pathology
  • Biomedical Engineering

Background:

  • Cardiac remodelling is key in heart failure, often studied using cardiomyocyte cross-sectional area (CSA) and microvascular density (MVD).
  • Current histological methods like immunohistochemistry require species-specific antibodies and optimized protocols.
  • Lectin histochemistry offers a cost-effective, cross-species alternative, but direct comparisons are limited.

Purpose of the Study:

  • To compare antibody-based and lectin-based methods for assessing cardiac CSA and MVD.
  • To develop and validate a combined lectin histochemistry protocol ('CardiLect') for cardiac remodelling assessment.
  • To provide an automated image analysis tool for histological data.

Main Methods:

  • Compared anti-laminin/wheat germ agglutinin (WGA) for CSA and anti-CD31/isolectin B4 (ILB4) for MVD.
  • Developed the 'CardiLect' protocol using WGA and ILB4, tested across species (zebrafish, rodents, large animals, humans).
  • Created an ImageJ script ('CardiLect Analyser') for automated analysis and validated it against echocardiographic findings.

Main Results:

  • The 'CardiLect' protocol demonstrated efficacy across multiple species for assessing cardiac remodelling.
  • Automated analysis showed significant correlations: CSA with left ventricular (LV) mass and ejection fraction (EF); MVD with LV mass and EF.
  • Histological parameters correlated significantly with echocardiographic indicators of cardiac function and mass.

Conclusions:

  • The 'CardiLect' protocol and 'CardiLect Analyser' offer an easy-to-use, cost-effective, and cross-species solution for histological assessment of cardiac remodelling.
  • This approach simplifies and enhances the study of cardiac remodelling in diverse preclinical and clinical models.
  • The validated protocol and analysis tool facilitate accurate and efficient evaluation of cardiac structural changes.
Abstract

Related Concept Videos